Rational site-directed pharmacotherapy for major d

更新时间:2023-06-14 00:08:41 阅读: 评论:0

Rational site-directed pharmacotherapy for major
跻身于depressive disorder
期刊名称: International Journal of Neuropsychopharmacology
erotic>软件本地化作者: Blier Pierre
guerny>blh
可圈可点试题网年份: 2014年from the heart
亵渎的意思期号: 第7期
关键词: Antidepressants;atypical antipsychotic;drug
combination;monoamines;polypharmacy
摘要:It is now accepted that major depressive disorder (MDD) is not a single pathophysiological entity. It is therefore not surprising that remission rates to a first antidepressant trial are low. In addition, antidepressants may target various neuronal elements for which there are gene polymorphisms, such telon
从小事做起 英语as the rotonin (5-HT) reuptake transporter, which may modulate respon. Acting on a single monoaminergic target, such as inhibiting the 5-HT transporter, may confer efficacy in MDD, but other targets may be ud and/or combined in treatment-resistant patients. The include the blockade of norepinephrine transporters, monoamine oxida, 5-HT(2A), 5-HT(1B) and 5-HT7 receptors, and the activation of 5-HT(1A) and dopamine 2 receptors. While antidepressants may have more than one of the properties, so do atypical antipsychotics.
内容由中国教育图书进出口有限公司引进

本文发布于:2023-06-14 00:08:41,感谢您对本站的认可!

本文链接:https://www.wtabcd.cn/fanwen/fan/78/948449.html

版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。

标签:教育   图书   进出口   有限公司
相关文章
留言与评论(共有 0 条评论)
   
验证码:
推荐文章
排行榜
Copyright ©2019-2022 Comsenz Inc.Powered by © 专利检索| 网站地图